Skip to content
SentinelMarket desk
Switch to dark mode

이연제약

102460KOSPIView the 제약 sectorTheme Bio & healthcare

9,940KRWMarket close of 10/20 (Tue)

Up +0.51%+50KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)9,920KRWDown -0.20%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
9,700
High
9,940
Low
9,590
Day range
Day range low 9,590 high 9,940, open 9,700, close 9,940, previous close 9,890
Volume
3×10K shares
261.17 million KRW 0.97× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 9,770 to 12,570 won, 6% up from the low

6% of the way up from the lowest close in 1 year (252 sessions) · -20.9% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-33.1B KRWOperating income over the last four quarters -33.1B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move+0.51%usual range
  • Trading value1.0×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue36.1B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -1.9%
    vs. prior quarter
    +6.4%
  • Operating income-6.7B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-18.5%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -8.1 pp
    vs. prior quarter
    +5.6 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15
2021Q1 1.5B KRW2026Q1 -6.7B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.